Gonyer David A 4
4 · Evoke Pharma Inc · Filed Feb 10, 2023
Insider Transaction Report
Form 4
Evoke Pharma IncEVOK
Gonyer David A
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2023-02-08+30,000→ 30,000 totalExercise: $4.01Exp: 2033-02-07→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The option shall vest at the rate of 1/48th of the original number of shares on each monthly anniversary of January 1, 2023, subject to the reporting person's continuous service to the issuer on each such vesting date.